Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
About Us
BoD
Patrick Langlois - Director
-
Dr. Patrick Langlois was the CFO and Vice Chairman of the Management Board of Aventis from 2002 to 2005 and for 30 years served in various senior financial functions in Rhône-Poulenc and Aventis Group in France and the USA. Prior to that, he was with Banque Louis Dreyfuss. He is presently General Partner of PJL Conseils, a consulting firm in Healthcare.